Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,492.00    -58.00 (-3.74%)
Bid:
1,490.00
Ask:
1,498.00
Spread: 8.00 (0.537%)
Market Cap: £778.29m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

CPO Export levy update

18 Mar 2022 16:04

RNS Number : 3330F
M. P. Evans Group PLC
18 March 2022
 

M.P. EVANS GROUP PLC

("the Group" or "M.P.Evans")

 

INDONESIAN GOVERNMENT ANNOUNCES REVISIONS TO EXPORT LEVY

M.P.Evans Group PLC, a producer of sustainable Indonesian palm oil, announces revisions made by the Indonesian government to its palm-oil export levy following the recent record-high prices. These will take immediate effect (see Annex) and result in an increase in the export levy of up to US$200 per tonne, dependent on the reference price of crude palm oil ("CPO") used, which is closely linked to the cif Rotterdam price. The Indonesian government had recently introduced a domestic market obligation ("DMO") to subsidise local palm-oil supplies, but this is being withdrawn and replaced with the revised levy.

 

It is not entirely clear to what extent the DMO had already resulted in downward pressure on mill-gate prices. However, following its withdrawal and the introduction of the revised levy, the Group continues to receive strong pricing for its CPO. US$1,080 per tonne was achieved for a tender today, similar to pricing achieved just before the levy's introduction and significantly higher than the 2021 average of US$810 per tonne. Management continues to monitor the situation closely.

 

 

The Group will be announcing its 2021 results on Tuesday 22 March.

 

 

 

 

18 March 2022

 

 

 

Enquiries:

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster

Andrew Clark

Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern

Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack

Elfie Kent

 

 

 

 

 

 

 

 

 

ANNEX

 

Reference price

Net price at top of

Net price under prior

From

To

 Levy

Tax

 Total

band

structure

0

750

55

55

695

695

751

800

75

3

78

722

722

801

850

95

18

113

737

737

851

900

115

33

148

752

752

901

950

135

52

187

763

763

951

1,000

155

74

229

771

771

1,001

1,050

175

93

268

782

782

1,051

1,100

195

116

311

789

809

1,101

1,150

215

144

359

791

831

1,151

1,200

235

166

401

799

859

1,201

1,250

255

183

438

812

892

1,251

1,300

275

200

475

825

925

1,301

1,350

295

200

495

855

975

1,351

1,400

315

200

515

885

1,025

1,401

1,450

335

200

535

915

1,075

1,451

1,500

355

200

555

945

1,125

1,501

375

200

575

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKDPFEAAEFA
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.